Application | Comment | Organism |
---|---|---|
pharmacology | Cdr1p is a critical factor in the design of therapeutic strategies to combat antifungal resistance | Candida albicans |
Cloned (Comment) | Organism |
---|---|
CDR1, overexpression in Saccharomyces cerevisiae AD1-8u- | Candida albicans |
Protein Variants | Comment | Organism |
---|---|---|
C193K | residue of the Walker A motif of the N-terminal nucleotide binding domain, mutant with 22% ATPase activity compared with native Cdr1p, mutant cells are not hypersensitive to drugs such as fluconazole, ansiomycin, miconazole or cycloheximide | Candida albicans |
C193K/K901 | double mutant has an ATPase activity below 10% compared with native Cdr1p | Candida albicans |
K901C | residue of the Walker A motif of the C-terminal nucleotide binding domain, mutant with 12% ATPase activity compared with native Cdr1p, mutant cells are hypersensitive to drugs such as fluconazole, ansiomycin, miconazole or cycloheximide and are unable to expel rhodamine 6G | Candida albicans |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
plasma membrane | transmembrane protein | Candida albicans | 5886 | - |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + H2O + azole/in | Candida albicans | the ABC multidrug transporter Cdr1p plays a key role in azole resistance | ADP + phosphate + azole/out | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Candida albicans | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + H2O + anisomycin/in | recombinant Cdr1p | Candida albicans | ADP + phosphate + anisomycin/out | - |
? | |
ATP + H2O + azole/in | the ABC multidrug transporter Cdr1p plays a key role in azole resistance | Candida albicans | ADP + phosphate + azole/out | - |
? | |
ATP + H2O + cycloheximide/in | recombinant Cdr1p | Candida albicans | ADP + phosphate + cycloheximide/out | - |
? | |
ATP + H2O + fluconazole/in | recombinant Cdr1p | Candida albicans | ADP + phosphate + fluconazole/out | - |
? | |
ATP + H2O + miconazole/in | recombinant Cdr1p | Candida albicans | ADP + phosphate + miconazole/out | - |
? | |
ATP + H2O + rhodamine 6G/in | recombinant Cdr1p | Candida albicans | ADP + phosphate + rhodamine 6G/out | - |
? | |
ATP + H2O + xenobiotic/in | ABC multidrug transporter Cdr1p, domain structure, roles of Cys-193 of the Walker A motif of the N-terminal nucleotide binding domain and of Lys-901 of the Walker A motif of the C-terminal nucleotide binding domain in ATPase function, the two nucleotide binding domains influence the Cdr1p function asymmetrically | Candida albicans | ADP + phosphate + xenobiotic/out | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Cdr1p | - |
Candida albicans |